Iron Status of Multiple Transfused Sickle Cell Anaemia Patients Attending a Sickle Cell Clinic in Benin City, Nigeria


This study was aimed at evaluating the iron status of multiple blood transfused sickle cell anaemia (SCA) patients in Benin City, Nigeria. A total of 86 subjects participated in the study, comprising of 30 multiple transfused SCA subjects, 30 of rarely transfused SCA subjects and 26 of age and sex matched healthy control subjects. Serum ferritin was determined by enzyme linked immuno sorbent assay technique. Serum iron and Total iron binding capacity was determined by spectrophometric method. The mean serum ferritin concentration was elevated in the sickle cell anaemia patients whose multiple transfusions (MT) are more than those who were rarely transfused (RT) as compared with the control groups (p < 0.001). There was a positive correlation between the serum ferritin and the number of units of blood transfused (r = 0.719, p = 0.000). This study revealed that a high level of serum ferritin, percentage transferrin saturation and a reduction in total iron binding capacity were observed in sickle cell anaemia patients who received ≥3 units of packed cells in one year.

Share and Cite:

Ikusemoro, A. , Halim, N. , Awodu, O. , Ehiaghe, F. , Isoa, E. and Ehiaghe, I. (2014) Iron Status of Multiple Transfused Sickle Cell Anaemia Patients Attending a Sickle Cell Clinic in Benin City, Nigeria. Open Journal of Pathology, 4, 25-31. doi: 10.4236/ojpathology.2014.42005.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Akinyanju, O.O. (1989) A Profile of Sickle Cell Disease in Nigeria. Annals of the New York Academy of Sciences, 565, 126-136.
[2] Edelstein, S.J. (1981) Molecular Topology in Crystals and Fibers of Hemoglobin S. Journal of Molecular Biology, 150, 557-575.
[3] Walter, P.B., Harmatz, P. and Vishinski, E. (2009) Iron Metabolism and Iron Chelation in Sickle Cell Disease. Acta Hematological, 122, 174-183.
[4] Pippard, M., Johnson, D., Callender, S. and Finch, C. (1982) Ferrioxamine Excretion in Iron Loaded Man. Blood, 60, 286-294.
[5] Ohene-Frempong, K. and Nkrumah, F.K. (1994) Sickle Cell Disease in Africa. In: Embury, S.H., Hebbel, R.P., Mohandas, N., Eds., Sickle Cell Disease: Basic Principles and Clinical Practice, Raven Press Ltd., New York, 423-435.
[6] Platt, O., Thorington, M.S. and Brambilla, D.J. (1991) Pain in Sickle Cell Disease—Rates and Risk Factors. The New England Journal of Medicine, 325, 11-16.
[7] Naing, L., Winn, T. and Rush, B.N. (2006) Practical Issues in Calculating the Sample Size for Prevalence Studies. Archives of Orofacial Sciences, 1, 9-14.
[8] Tietz, N.W. (1984) Fundamentals of Clinical Chemistry. W.B. Saunders, Philadelphia.
[9] Davies, S., Henthorn, J. and Brozovic, M. (1983) Iron Deficiency in Sickle Cell Anaemia. Journal of Clinical Pathology, 36, 1012-1015.
[10] Mahoney, B.S., Ambruso, D.R. and Githens, J.H. (1978) Iron Studies in Sickle Cell Anaemia. Journal of Pediatrics, 93, 1070.
[11] Serjeant, G.R. (1992) Sickle Cell Disease. Oxford University Press, Oxford.
[12] Peterson, C.M., Crazino, J.H. and Ciutiis, A. (1975) Iron Metabolism, Sickle cell Disease and Response to Cyanate. Blood, 46, 583-590.
[13] Hussain, M.A.M., Davis, L.R., Laulicht, M. and Hoffbrand, A.V. (1978) Value of Serum Ferritin Estimation in Sickle Cell Anaemia. Archives of Disease in Childhood, 53, 319-321.
[14] Oluboyede, O.A., Usanga, E.A., Lukambi, F.A. and Ajayi, O.A. (1996) Evaluation of Serum Ferritin Levels and Other Hematological Parameters in a Nigerian Population. Journal of the National Medical Association, 75, 885-889.
[15] Aken’Ova, Y.A., Adaefai, C. and Okunade, M. (1997) Ferritin and Serum Iron Levels in Adult Patients with Sickle Cell Anaemia in Ibadan, Nigeria. African Journal of Medicine & Medical Sciences, 26, 39-41.
[16] Hoffbrand, A.V., Daniel, C. and Edward, G.D. (2004) Sickle Cell Disease, Postgraduate Haematology. 5th Edition, Blackwell Publishing, Oxford.
[17] Powars, D.R. (1975) Natural History of Sickle Cell Disease—The First Ten Years. Seminars in Hematology, 12, 267-285
[18] Biergegard, G., Hogman, C., Killander, A., Levander, H., Simsson, B. and Wide, L. (1977). Serum Ferritin and Erythrocyte 2, 3-DPG during Phlebotomy and Iron Treatment. Scandinavian Journal of Haematology, 19, 327-33.
[19] Cook, J.D. and Finch, C.A. (1979) Assessing the Iron Status of a Population. The American Journal of Clinical Nutrition, 32, 2115-2119.
[20] Legget, B.A., Brown, N.N., Bryant, S.J., Dullock, L. and Powell, L.W. (1990) Factors Affecting the Concentration of Ferritin in the Serum of Healthy Australian Population. Clinical Chemistry, 36, 1350-1355.
[21] Cardeza, T.D. (2001) Foundation for Hematologic Research Philadelphia USA. Seminars in Hematology, 38, 30-36.
[22] Ballas, S.K. (2001) Iron Overload Is a Determinant of Morbidity and Mortality in Adult Patients with Sickle Cell Disease. Seminars in Hematology, 38, 30-36.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.